Growth differences associated with compulsive and stereotyped behavior disorders in adults with mental retardation

Anxiety

Volumn 2, Issue 2, 1996, Pages 90-94

  Powell, Susan B ^a   Bodfish, James W ^b   Parker, Dawn E ^b   Crawford, Timothy W ^b   Golden, Robert N ^c   Lewis, Mark H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Western Carolina Center   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Height; Movement disorders; Neuroendocrine; Self injurious behavior; Weight developmental disabilities

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; COMPULSION; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; MIDDLE AGED; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REFERENCE VALUE; SEX DIFFERENCE; STEREOTYPY;

ADOLESCENT; ADULT; AGED; BODY HEIGHT; BODY WEIGHT; COMPULSIVE BEHAVIOR; FEMALE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; NEUROSECRETORY SYSTEMS; REFERENCE VALUES; SEX FACTORS; STEREOTYPED BEHAVIOR;

EID: 0030325095     PISSN: 10709797     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-7154(1996)2:2<90::AID-ANXI5>3.0.CO;2-H     Document Type: Article

References (17)

1. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW (1992) Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 49:9-20.
2. Bodfish JW, Madison JM (1993) Diagnosis and fluoxetine treatment of compulsive behavior disorders in adults with mental retardation. Am J Ment Retard 98:360-367.
3. Bodfish JW, Crawford TW, Powell SB, Golden RN, Lewis MH (1995b) Compulsions in adults with mental retardation: Prevalence, phenomenology, and co-morbidity with stereotypy and self-injury. Am J Ment Retard 100:183-192.
4. Bodfish JW, Powell SB, Golden RN, Lewis MH (1995a) Blink rate as an index of dopamine function in adults with mental retardation and repetitive behavior disorders. Am J Mental Retardation 99:335-344.
5. Gedye A (1992) Recognizing obsessive-compulsive disorder in clients with developmental disabilities. Hab Ment Healthcare Newslt 11:73-80.
6. Hamburger SD, Swedo S, Whitaker A, Davies M, Rapoport JL (1989) Growth rate in adolescents with obsessive-compulsive disorder. Am J Psychiatry 14:652-655.
7. Havlicek V, Rezek M, Friesen H (1976) Somatostatin and thyrotropin releasing hormone: Central effects on sleep and motor systems. Pharmacol Biochem Behav 4:455-459.
8. Kruesi MJ, Swedo S, Leonard H, Rubinow DR, Rapoport JL (1990) CSF somatostatin in childhood psychiatric disorders: A preliminary investigation. Psychiatry Res 33:277-284.
9. Lewis MH, Gluck JP, Bodfish JW, Beauchamp AJ, Mailman RB (1996a) Neurobiological basis of stereotyped movement disorder in animals and humans. In: Sprague RL, Newell KM (eds.) Ste-reotypy: Brain Behavior Relationships. Washington, DC: American Psychological Association Press, in press.
10. Lewis MH, Bodfish JW, Powell SB, Golden RN (1995) Clomipramine treatment for stereotypy and related repetitive movement disorders associated with mental retardation. Am J Mental Retard 100:299-312.
11. Lewis MH, Bodfish JW, Powell SB, Wiest K, Darling M, Golden RN (1996b) Plasma HVA in adults with mental retardation and stereotyped behavior: Biochemical evidence for a dopamine deficiency model. Am J Ment Retard, in press.
12. Mosier HD, Grossman HJ, Dingman HF (1965) Physical growth in mental defectives: A study in an institutionalized population. Pediatrics 36:465-519.
13. Rapoport JL, Wise SP (1988) Obsessive-compulsive disorder: Evidence for basal ganglia dysfunction. Psychopharmacol Bull 24:380-384.
14. Sandman CA, Barren JL, Chicz-DeMet A, DeMet EM (1990) Plasma β-endorphin levels in patients with self-injurious behavior and stereotypy. Am J Ment Retard 95:84-92.
15. Uhde TW, Malloy LC, Slate SO (1992a) Fearful behavior, body size, and serum IGF-I levels in nervous pointer dogs. Pharmacol Biochem Behav 43:263-269.
16. Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger J, Vittone B, Gurgis G, Geraci M, Black B, Post RM (1992b) Evidence for hypothalamic-growth hormone dysfunction in panic disorder: Profile of growth hormone (GH) response to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology 6:101-118.
17. Vitiello B, Spreat S, Behar D (1989) Obsessive-compulsive disorder in mentally retarded patients. J Nerv Ment Dis 177:232-236.